Perspective of the GEMSTONE Consortium on Current and Future Approaches to Functional Validation for Skeletal Genetic Disease Using Cellular, Molecular and Animal-Modeling Techniques

The availability of large human datasets for genome-wide association studies (GWAS) and the advancement of sequencing technologies have boosted the identification of genetic variants in complex and rare diseases in the skeletal field. Yet, interpreting results from human association studies remains...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Martina Rauner, Ines Foessl, Melissa M. Formosa, Erika Kague, Vid Prijatelj, Nerea Alonso Lopez, Bodhisattwa Banerjee, Dylan Bergen, Björn Busse, Ângelo Calado, Eleni Douni, Yankel Gabet, Natalia García Giralt, Daniel Grinberg, Nika M. Lovsin, Xavier Nogues Solan, Barbara Ostanek, Nathan J. Pavlos, Fernando Rivadeneira, Ivan Soldatovic, Jeroen van de Peppel, Bram van der Eerden, Wim van Hul, Susanna Balcells, Janja Marc, Sjur Reppe, Kent Søe, David Karasik
Formato: article
Lenguaje:EN
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://doaj.org/article/ab5cda7f24e346b4a98b3e682c545407
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:ab5cda7f24e346b4a98b3e682c545407
record_format dspace
spelling oai:doaj.org-article:ab5cda7f24e346b4a98b3e682c5454072021-12-01T19:45:37ZPerspective of the GEMSTONE Consortium on Current and Future Approaches to Functional Validation for Skeletal Genetic Disease Using Cellular, Molecular and Animal-Modeling Techniques1664-239210.3389/fendo.2021.731217https://doaj.org/article/ab5cda7f24e346b4a98b3e682c5454072021-11-01T00:00:00Zhttps://www.frontiersin.org/articles/10.3389/fendo.2021.731217/fullhttps://doaj.org/toc/1664-2392The availability of large human datasets for genome-wide association studies (GWAS) and the advancement of sequencing technologies have boosted the identification of genetic variants in complex and rare diseases in the skeletal field. Yet, interpreting results from human association studies remains a challenge. To bridge the gap between genetic association and causality, a systematic functional investigation is necessary. Multiple unknowns exist for putative causal genes, including cellular localization of the molecular function. Intermediate traits (“endophenotypes”), e.g. molecular quantitative trait loci (molQTLs), are needed to identify mechanisms of underlying associations. Furthermore, index variants often reside in non-coding regions of the genome, therefore challenging for interpretation. Knowledge of non-coding variance (e.g. ncRNAs), repetitive sequences, and regulatory interactions between enhancers and their target genes is central for understanding causal genes in skeletal conditions. Animal models with deep skeletal phenotyping and cell culture models have already facilitated fine mapping of some association signals, elucidated gene mechanisms, and revealed disease-relevant biology. However, to accelerate research towards bridging the current gap between association and causality in skeletal diseases, alternative in vivo platforms need to be used and developed in parallel with the current -omics and traditional in vivo resources. Therefore, we argue that as a field we need to establish resource-sharing standards to collectively address complex research questions. These standards will promote data integration from various -omics technologies and functional dissection of human complex traits. In this mission statement, we review the current available resources and as a group propose a consensus to facilitate resource sharing using existing and future resources. Such coordination efforts will maximize the acquisition of knowledge from different approaches and thus reduce redundancy and duplication of resources. These measures will help to understand the pathogenesis of osteoporosis and other skeletal diseases towards defining new and more efficient therapeutic targets.Martina RaunerMartina RaunerInes FoesslMelissa M. FormosaMelissa M. FormosaErika KagueVid PrijateljVid PrijateljVid PrijateljNerea Alonso LopezBodhisattwa BanerjeeDylan BergenDylan BergenBjörn BusseÂngelo CaladoEleni DouniEleni DouniYankel GabetNatalia García GiraltDaniel GrinbergNika M. LovsinXavier Nogues SolanBarbara OstanekNathan J. PavlosFernando RivadeneiraIvan SoldatovicJeroen van de PeppelBram van der EerdenWim van HulSusanna BalcellsJanja MarcSjur ReppeSjur ReppeSjur ReppeKent SøeKent SøeKent SøeDavid KarasikDavid KarasikFrontiers Media S.A.articlegenome-wide association studymusculoskeletal diseasegene regulationanimal modelsdata integration analysisDiseases of the endocrine glands. Clinical endocrinologyRC648-665ENFrontiers in Endocrinology, Vol 12 (2021)
institution DOAJ
collection DOAJ
language EN
topic genome-wide association study
musculoskeletal disease
gene regulation
animal models
data integration analysis
Diseases of the endocrine glands. Clinical endocrinology
RC648-665
spellingShingle genome-wide association study
musculoskeletal disease
gene regulation
animal models
data integration analysis
Diseases of the endocrine glands. Clinical endocrinology
RC648-665
Martina Rauner
Martina Rauner
Ines Foessl
Melissa M. Formosa
Melissa M. Formosa
Erika Kague
Vid Prijatelj
Vid Prijatelj
Vid Prijatelj
Nerea Alonso Lopez
Bodhisattwa Banerjee
Dylan Bergen
Dylan Bergen
Björn Busse
Ângelo Calado
Eleni Douni
Eleni Douni
Yankel Gabet
Natalia García Giralt
Daniel Grinberg
Nika M. Lovsin
Xavier Nogues Solan
Barbara Ostanek
Nathan J. Pavlos
Fernando Rivadeneira
Ivan Soldatovic
Jeroen van de Peppel
Bram van der Eerden
Wim van Hul
Susanna Balcells
Janja Marc
Sjur Reppe
Sjur Reppe
Sjur Reppe
Kent Søe
Kent Søe
Kent Søe
David Karasik
David Karasik
Perspective of the GEMSTONE Consortium on Current and Future Approaches to Functional Validation for Skeletal Genetic Disease Using Cellular, Molecular and Animal-Modeling Techniques
description The availability of large human datasets for genome-wide association studies (GWAS) and the advancement of sequencing technologies have boosted the identification of genetic variants in complex and rare diseases in the skeletal field. Yet, interpreting results from human association studies remains a challenge. To bridge the gap between genetic association and causality, a systematic functional investigation is necessary. Multiple unknowns exist for putative causal genes, including cellular localization of the molecular function. Intermediate traits (“endophenotypes”), e.g. molecular quantitative trait loci (molQTLs), are needed to identify mechanisms of underlying associations. Furthermore, index variants often reside in non-coding regions of the genome, therefore challenging for interpretation. Knowledge of non-coding variance (e.g. ncRNAs), repetitive sequences, and regulatory interactions between enhancers and their target genes is central for understanding causal genes in skeletal conditions. Animal models with deep skeletal phenotyping and cell culture models have already facilitated fine mapping of some association signals, elucidated gene mechanisms, and revealed disease-relevant biology. However, to accelerate research towards bridging the current gap between association and causality in skeletal diseases, alternative in vivo platforms need to be used and developed in parallel with the current -omics and traditional in vivo resources. Therefore, we argue that as a field we need to establish resource-sharing standards to collectively address complex research questions. These standards will promote data integration from various -omics technologies and functional dissection of human complex traits. In this mission statement, we review the current available resources and as a group propose a consensus to facilitate resource sharing using existing and future resources. Such coordination efforts will maximize the acquisition of knowledge from different approaches and thus reduce redundancy and duplication of resources. These measures will help to understand the pathogenesis of osteoporosis and other skeletal diseases towards defining new and more efficient therapeutic targets.
format article
author Martina Rauner
Martina Rauner
Ines Foessl
Melissa M. Formosa
Melissa M. Formosa
Erika Kague
Vid Prijatelj
Vid Prijatelj
Vid Prijatelj
Nerea Alonso Lopez
Bodhisattwa Banerjee
Dylan Bergen
Dylan Bergen
Björn Busse
Ângelo Calado
Eleni Douni
Eleni Douni
Yankel Gabet
Natalia García Giralt
Daniel Grinberg
Nika M. Lovsin
Xavier Nogues Solan
Barbara Ostanek
Nathan J. Pavlos
Fernando Rivadeneira
Ivan Soldatovic
Jeroen van de Peppel
Bram van der Eerden
Wim van Hul
Susanna Balcells
Janja Marc
Sjur Reppe
Sjur Reppe
Sjur Reppe
Kent Søe
Kent Søe
Kent Søe
David Karasik
David Karasik
author_facet Martina Rauner
Martina Rauner
Ines Foessl
Melissa M. Formosa
Melissa M. Formosa
Erika Kague
Vid Prijatelj
Vid Prijatelj
Vid Prijatelj
Nerea Alonso Lopez
Bodhisattwa Banerjee
Dylan Bergen
Dylan Bergen
Björn Busse
Ângelo Calado
Eleni Douni
Eleni Douni
Yankel Gabet
Natalia García Giralt
Daniel Grinberg
Nika M. Lovsin
Xavier Nogues Solan
Barbara Ostanek
Nathan J. Pavlos
Fernando Rivadeneira
Ivan Soldatovic
Jeroen van de Peppel
Bram van der Eerden
Wim van Hul
Susanna Balcells
Janja Marc
Sjur Reppe
Sjur Reppe
Sjur Reppe
Kent Søe
Kent Søe
Kent Søe
David Karasik
David Karasik
author_sort Martina Rauner
title Perspective of the GEMSTONE Consortium on Current and Future Approaches to Functional Validation for Skeletal Genetic Disease Using Cellular, Molecular and Animal-Modeling Techniques
title_short Perspective of the GEMSTONE Consortium on Current and Future Approaches to Functional Validation for Skeletal Genetic Disease Using Cellular, Molecular and Animal-Modeling Techniques
title_full Perspective of the GEMSTONE Consortium on Current and Future Approaches to Functional Validation for Skeletal Genetic Disease Using Cellular, Molecular and Animal-Modeling Techniques
title_fullStr Perspective of the GEMSTONE Consortium on Current and Future Approaches to Functional Validation for Skeletal Genetic Disease Using Cellular, Molecular and Animal-Modeling Techniques
title_full_unstemmed Perspective of the GEMSTONE Consortium on Current and Future Approaches to Functional Validation for Skeletal Genetic Disease Using Cellular, Molecular and Animal-Modeling Techniques
title_sort perspective of the gemstone consortium on current and future approaches to functional validation for skeletal genetic disease using cellular, molecular and animal-modeling techniques
publisher Frontiers Media S.A.
publishDate 2021
url https://doaj.org/article/ab5cda7f24e346b4a98b3e682c545407
work_keys_str_mv AT martinarauner perspectiveofthegemstoneconsortiumoncurrentandfutureapproachestofunctionalvalidationforskeletalgeneticdiseaseusingcellularmolecularandanimalmodelingtechniques
AT martinarauner perspectiveofthegemstoneconsortiumoncurrentandfutureapproachestofunctionalvalidationforskeletalgeneticdiseaseusingcellularmolecularandanimalmodelingtechniques
AT inesfoessl perspectiveofthegemstoneconsortiumoncurrentandfutureapproachestofunctionalvalidationforskeletalgeneticdiseaseusingcellularmolecularandanimalmodelingtechniques
AT melissamformosa perspectiveofthegemstoneconsortiumoncurrentandfutureapproachestofunctionalvalidationforskeletalgeneticdiseaseusingcellularmolecularandanimalmodelingtechniques
AT melissamformosa perspectiveofthegemstoneconsortiumoncurrentandfutureapproachestofunctionalvalidationforskeletalgeneticdiseaseusingcellularmolecularandanimalmodelingtechniques
AT erikakague perspectiveofthegemstoneconsortiumoncurrentandfutureapproachestofunctionalvalidationforskeletalgeneticdiseaseusingcellularmolecularandanimalmodelingtechniques
AT vidprijatelj perspectiveofthegemstoneconsortiumoncurrentandfutureapproachestofunctionalvalidationforskeletalgeneticdiseaseusingcellularmolecularandanimalmodelingtechniques
AT vidprijatelj perspectiveofthegemstoneconsortiumoncurrentandfutureapproachestofunctionalvalidationforskeletalgeneticdiseaseusingcellularmolecularandanimalmodelingtechniques
AT vidprijatelj perspectiveofthegemstoneconsortiumoncurrentandfutureapproachestofunctionalvalidationforskeletalgeneticdiseaseusingcellularmolecularandanimalmodelingtechniques
AT nereaalonsolopez perspectiveofthegemstoneconsortiumoncurrentandfutureapproachestofunctionalvalidationforskeletalgeneticdiseaseusingcellularmolecularandanimalmodelingtechniques
AT bodhisattwabanerjee perspectiveofthegemstoneconsortiumoncurrentandfutureapproachestofunctionalvalidationforskeletalgeneticdiseaseusingcellularmolecularandanimalmodelingtechniques
AT dylanbergen perspectiveofthegemstoneconsortiumoncurrentandfutureapproachestofunctionalvalidationforskeletalgeneticdiseaseusingcellularmolecularandanimalmodelingtechniques
AT dylanbergen perspectiveofthegemstoneconsortiumoncurrentandfutureapproachestofunctionalvalidationforskeletalgeneticdiseaseusingcellularmolecularandanimalmodelingtechniques
AT bjornbusse perspectiveofthegemstoneconsortiumoncurrentandfutureapproachestofunctionalvalidationforskeletalgeneticdiseaseusingcellularmolecularandanimalmodelingtechniques
AT angelocalado perspectiveofthegemstoneconsortiumoncurrentandfutureapproachestofunctionalvalidationforskeletalgeneticdiseaseusingcellularmolecularandanimalmodelingtechniques
AT elenidouni perspectiveofthegemstoneconsortiumoncurrentandfutureapproachestofunctionalvalidationforskeletalgeneticdiseaseusingcellularmolecularandanimalmodelingtechniques
AT elenidouni perspectiveofthegemstoneconsortiumoncurrentandfutureapproachestofunctionalvalidationforskeletalgeneticdiseaseusingcellularmolecularandanimalmodelingtechniques
AT yankelgabet perspectiveofthegemstoneconsortiumoncurrentandfutureapproachestofunctionalvalidationforskeletalgeneticdiseaseusingcellularmolecularandanimalmodelingtechniques
AT nataliagarciagiralt perspectiveofthegemstoneconsortiumoncurrentandfutureapproachestofunctionalvalidationforskeletalgeneticdiseaseusingcellularmolecularandanimalmodelingtechniques
AT danielgrinberg perspectiveofthegemstoneconsortiumoncurrentandfutureapproachestofunctionalvalidationforskeletalgeneticdiseaseusingcellularmolecularandanimalmodelingtechniques
AT nikamlovsin perspectiveofthegemstoneconsortiumoncurrentandfutureapproachestofunctionalvalidationforskeletalgeneticdiseaseusingcellularmolecularandanimalmodelingtechniques
AT xaviernoguessolan perspectiveofthegemstoneconsortiumoncurrentandfutureapproachestofunctionalvalidationforskeletalgeneticdiseaseusingcellularmolecularandanimalmodelingtechniques
AT barbaraostanek perspectiveofthegemstoneconsortiumoncurrentandfutureapproachestofunctionalvalidationforskeletalgeneticdiseaseusingcellularmolecularandanimalmodelingtechniques
AT nathanjpavlos perspectiveofthegemstoneconsortiumoncurrentandfutureapproachestofunctionalvalidationforskeletalgeneticdiseaseusingcellularmolecularandanimalmodelingtechniques
AT fernandorivadeneira perspectiveofthegemstoneconsortiumoncurrentandfutureapproachestofunctionalvalidationforskeletalgeneticdiseaseusingcellularmolecularandanimalmodelingtechniques
AT ivansoldatovic perspectiveofthegemstoneconsortiumoncurrentandfutureapproachestofunctionalvalidationforskeletalgeneticdiseaseusingcellularmolecularandanimalmodelingtechniques
AT jeroenvandepeppel perspectiveofthegemstoneconsortiumoncurrentandfutureapproachestofunctionalvalidationforskeletalgeneticdiseaseusingcellularmolecularandanimalmodelingtechniques
AT bramvandereerden perspectiveofthegemstoneconsortiumoncurrentandfutureapproachestofunctionalvalidationforskeletalgeneticdiseaseusingcellularmolecularandanimalmodelingtechniques
AT wimvanhul perspectiveofthegemstoneconsortiumoncurrentandfutureapproachestofunctionalvalidationforskeletalgeneticdiseaseusingcellularmolecularandanimalmodelingtechniques
AT susannabalcells perspectiveofthegemstoneconsortiumoncurrentandfutureapproachestofunctionalvalidationforskeletalgeneticdiseaseusingcellularmolecularandanimalmodelingtechniques
AT janjamarc perspectiveofthegemstoneconsortiumoncurrentandfutureapproachestofunctionalvalidationforskeletalgeneticdiseaseusingcellularmolecularandanimalmodelingtechniques
AT sjurreppe perspectiveofthegemstoneconsortiumoncurrentandfutureapproachestofunctionalvalidationforskeletalgeneticdiseaseusingcellularmolecularandanimalmodelingtechniques
AT sjurreppe perspectiveofthegemstoneconsortiumoncurrentandfutureapproachestofunctionalvalidationforskeletalgeneticdiseaseusingcellularmolecularandanimalmodelingtechniques
AT sjurreppe perspectiveofthegemstoneconsortiumoncurrentandfutureapproachestofunctionalvalidationforskeletalgeneticdiseaseusingcellularmolecularandanimalmodelingtechniques
AT kentsøe perspectiveofthegemstoneconsortiumoncurrentandfutureapproachestofunctionalvalidationforskeletalgeneticdiseaseusingcellularmolecularandanimalmodelingtechniques
AT kentsøe perspectiveofthegemstoneconsortiumoncurrentandfutureapproachestofunctionalvalidationforskeletalgeneticdiseaseusingcellularmolecularandanimalmodelingtechniques
AT kentsøe perspectiveofthegemstoneconsortiumoncurrentandfutureapproachestofunctionalvalidationforskeletalgeneticdiseaseusingcellularmolecularandanimalmodelingtechniques
AT davidkarasik perspectiveofthegemstoneconsortiumoncurrentandfutureapproachestofunctionalvalidationforskeletalgeneticdiseaseusingcellularmolecularandanimalmodelingtechniques
AT davidkarasik perspectiveofthegemstoneconsortiumoncurrentandfutureapproachestofunctionalvalidationforskeletalgeneticdiseaseusingcellularmolecularandanimalmodelingtechniques
_version_ 1718404590577123328